Logo image of ECCC

EAGLE POINT CREDIT CO - ECC 6 1/2 06/30/31 (ECCC) Stock Fundamental Analysis

NYSE:ECCC - New York Stock Exchange, Inc. - US2698097035 - Currency: USD

22.94  -0.44 (-1.88%)

Fundamental Rating

3

ECCC gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. ECCC has a bad profitability rating. Also its financial health evaluation is rather negative. ECCC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ECCC was profitable.
ECCC had a negative operating cash flow in the past year.
ECCC had positive earnings in 4 of the past 5 years.
ECCC had negative operating cash flow in 4 of the past 5 years.
ECCC Yearly Net Income VS EBIT VS OCF VS FCFECCC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M -400M

1.2 Ratios

Industry RankSector Rank
ROA -3.6%
ROE -5.15%
ROIC 6.48%
ROA(3y)1.32%
ROA(5y)6.59%
ROE(3y)1.24%
ROE(5y)9.12%
ROIC(3y)6.93%
ROIC(5y)6.24%
ECCC Yearly ROA, ROE, ROICECCC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

ECCC's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of ECCC has grown nicely.
In the last couple of years the Gross Margin of ECCC has grown nicely.
Industry RankSector Rank
OM 60.46%
PM (TTM) N/A
GM 63.17%
OM growth 3Y5.72%
OM growth 5Y2.96%
PM growth 3Y-33.04%
PM growth 5YN/A
GM growth 3Y3%
GM growth 5Y2.17%
ECCC Yearly Profit, Operating, Gross MarginsECCC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for ECCC has been increased compared to 1 year ago.
Compared to 5 years ago, ECCC has more shares outstanding
ECCC has a worse debt/assets ratio than last year.
ECCC Yearly Shares OutstandingECCC Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ECCC Yearly Total Debt VS Total AssetsECCC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

ECCC has an Altman-Z score of 3.86. This indicates that ECCC is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.38 indicates that ECCC is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 3.86
ROIC/WACCN/A
WACCN/A
ECCC Yearly LT Debt VS Equity VS FCFECCC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 2.22 indicates that ECCC has no problem at all paying its short term obligations.
ECCC has a Quick Ratio of 2.22. This indicates that ECCC is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.22
Quick Ratio 2.22
ECCC Yearly Current Assets VS Current LiabilitesECCC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for ECCC have decreased strongly by -22.73% in the last year.
ECCC shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.24% yearly.
ECCC shows a strong growth in Revenue. In the last year, the Revenue has grown by 29.26%.
Measured over the past years, ECCC shows a very strong growth in Revenue. The Revenue has been growing by 22.03% on average per year.
EPS 1Y (TTM)-22.73%
EPS 3Y-5.35%
EPS 5Y-2.24%
EPS Q2Q%-35.29%
Revenue 1Y (TTM)29.26%
Revenue growth 3Y26.64%
Revenue growth 5Y22.03%
Sales Q2Q%14.54%

3.2 Future

Based on estimates for the next years, ECCC will show a decrease in Earnings Per Share. The EPS will decrease by -9.64% on average per year.
The Revenue is expected to grow by 16.22% on average over the next years. This is quite good.
EPS Next Y-12.57%
EPS Next 2Y-9.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.04%
Revenue Next 2Y16.22%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ECCC Yearly Revenue VS EstimatesECCC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
ECCC Yearly EPS VS EstimatesECCC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 22.49, the valuation of ECCC can be described as rather expensive.
Compared to an average S&P500 Price/Earnings ratio of 27.11, ECCC is valued at the same level.
A Price/Forward Earnings ratio of 24.01 indicates a rather expensive valuation of ECCC.
ECCC is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 35.78, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 22.49
Fwd PE 24.01
ECCC Price Earnings VS Forward Price EarningsECCC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ECCC Per share dataECCC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

A cheap valuation may be justified as ECCC's earnings are expected to decrease with -9.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.64%
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.95%, ECCC is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.39, ECCC pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.95%

5.2 History

ECCC has been paying a dividend for over 5 years, so it has already some track record.
The dividend of ECCC decreased recently.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
ECCC Yearly Dividends per shareECCC Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

ECCC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-326.46%
EPS Next 2Y-9.64%
EPS Next 3YN/A
ECCC Yearly Income VS Free CF VS DividendECCC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M -400M

More info and screens

EAGLE POINT CREDIT CO - ECC 6 1/2 06/30/31

NYSE:ECCC (8/13/2025, 7:04:06 PM)

22.94

-0.44 (-1.88%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-12 2025-08-12/bmo
Earnings (Next)11-12 2025-11-12/bmo
Inst Owners8.61%
Inst Owner ChangeN/A
Ins Owners0.18%
Ins Owner ChangeN/A
Market Cap2.76B
Analysts77.78
Price Target28.61 (24.72%)
Short Float %0%
Short Ratio0.65
Dividend
Industry RankSector Rank
Dividend Yield 6.95%
Yearly Dividend1.74
Dividend Growth(5Y)N/A
DP-326.46%
Div Incr Years0
Div Non Decr Years1
Ex-Date12-11 2025-12-11 (0.135417)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.14%
Min EPS beat(2)-13.9%
Max EPS beat(2)3.62%
EPS beat(4)2
Avg EPS beat(4)-5.6%
Min EPS beat(4)-13.9%
Max EPS beat(4)3.62%
EPS beat(8)3
Avg EPS beat(8)-6.78%
EPS beat(12)4
Avg EPS beat(12)-7.9%
EPS beat(16)6
Avg EPS beat(16)-5.88%
Revenue beat(2)0
Avg Revenue beat(2)-1.13%
Min Revenue beat(2)-1.41%
Max Revenue beat(2)-0.85%
Revenue beat(4)1
Avg Revenue beat(4)-1.27%
Min Revenue beat(4)-6.65%
Max Revenue beat(4)3.83%
Revenue beat(8)3
Avg Revenue beat(8)-1.05%
Revenue beat(12)6
Avg Revenue beat(12)-1.21%
Revenue beat(16)9
Avg Revenue beat(16)0.08%
PT rev (1m)10.7%
PT rev (3m)7.15%
EPS NQ rev (1m)-0.81%
EPS NQ rev (3m)-4.65%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.99%
Revenue NQ rev (1m)-0.55%
Revenue NQ rev (3m)-0.65%
Revenue NY rev (1m)-0.63%
Revenue NY rev (3m)-0.53%
Valuation
Industry RankSector Rank
PE 22.49
Fwd PE 24.01
P/S 14.44
P/FCF N/A
P/OCF N/A
P/B 2.71
P/tB 2.71
EV/EBITDA N/A
EPS(TTM)1.02
EY4.45%
EPS(NY)0.96
Fwd EY4.16%
FCF(TTM)-3.37
FCFYN/A
OCF(TTM)-3.37
OCFYN/A
SpS1.59
BVpS8.47
TBVpS8.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.6%
ROE -5.15%
ROCE 8.2%
ROIC 6.48%
ROICexc 6.48%
ROICexgc 6.48%
OM 60.46%
PM (TTM) N/A
GM 63.17%
FCFM N/A
ROA(3y)1.32%
ROA(5y)6.59%
ROE(3y)1.24%
ROE(5y)9.12%
ROIC(3y)6.93%
ROIC(5y)6.24%
ROICexc(3y)7.33%
ROICexc(5y)6.51%
ROICexgc(3y)7.34%
ROICexgc(5y)6.51%
ROCE(3y)8.78%
ROCE(5y)7.89%
ROICexcg growth 3Y7.57%
ROICexcg growth 5Y-0.43%
ROICexc growth 3Y7.47%
ROICexc growth 5Y-0.49%
OM growth 3Y5.72%
OM growth 5Y2.96%
PM growth 3Y-33.04%
PM growth 5YN/A
GM growth 3Y3%
GM growth 5Y2.17%
F-Score0
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 5.48
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.22
Quick Ratio 2.22
Altman-Z 3.86
F-Score0
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.73%
EPS 3Y-5.35%
EPS 5Y-2.24%
EPS Q2Q%-35.29%
EPS Next Y-12.57%
EPS Next 2Y-9.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)29.26%
Revenue growth 3Y26.64%
Revenue growth 5Y22.03%
Sales Q2Q%14.54%
Revenue Next Year22.04%
Revenue Next 2Y16.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y25.8%
EBIT growth 3Y33.88%
EBIT growth 5Y25.64%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-531.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-531.18%
OCF growth 3YN/A
OCF growth 5YN/A